{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-129595","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2022-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.377119+00:00","generated_at":"2026-06-20T23:57:17.225079+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NanoViricides annual meeting adjourned on redomicile proposal; directors re-elected, Diwan grant approved","bullets":["Directors Rokita (5.99M for), Jawadekar (5.95M for), Zucker (6.05M for) re-elected.","Approved 10,204 Series A Preferred Shares grant to President Anil Diwan (5.72M for, 1.01M against).","Ratified EisnerAmper as auditor for FY2023 (9.26M for, 88k against).","Redomicile to Delaware proposal did not pass; meeting adjourned to Feb 7, 2023 for further voting.","Quorum of 57% of voting shares was present at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-129595","json":"https://secwatch.observer/filing/0001104659-22-129595.json","markdown":"https://secwatch.observer/filing/0001104659-22-129595.md","text":"https://secwatch.observer/filing/0001104659-22-129595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465922129595/0001104659-22-129595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465922129595/tm2233401d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:57:17.225079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}